Semaglutide may be prescribed for type 2 diabetes, or to promote weight loss in people with obesity or overweight
Forest plot highlighting the risk of any cancer in the tirzepatide versus pooled control groups
At 12mg: Similar GI symptoms to the 8mg transition, though the body has already adapted to much of the receptor activation by this point
In parallel, Nooms intensive behavioral platform ensures that patients actually follow through on the diet and exercise recommendations that are meant to accompany the drug, thereby amplifying weight loss and fostering habit change that can last a lifetime
The 60-day guarantee is the appropriate risk-management tool - if the return channel is confirmed before ordering
Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
